While phase 3 TRIUMPH trials are outputting positive data, the drug must complete its full testing program and undergo a formal FDA safety and manufacturing review before it hits pharmacy shelves
c , Homeostatic model assessment of insulin resistance (HOMA-IR) (n = 7 Vhcl, n = 6 GLP-1:Lani, n = 8 GLP-1:GIP:Lani)
Retatrutide is generating more legitimate scientific interest than almost anything else in the weight loss and metabolic health space right now
Ginger extract has even been shown to regenerate pancreatic islets, the cells responsible for producing insulin and glucagon that can become damaged with insulin resistance and Type II Diabetes
This is a critical distinction
GLP-1 Targeted Peptide Weight Loss Drugs Market Share, by Dosage Strength, 20242034 Figure 5: U.S